<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2961406</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:540</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Bivalent EGFR-Targeting DARPin-MMAE Conjugates</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Lennard</namePart>
  <namePart type="family">Karsten</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">293723759</identifier></name>
<name type="personal">
  <namePart type="given">Nils</namePart>
  <namePart type="family">Janson</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">147294847</identifier></name>
<name type="personal">
  <namePart type="given">Vadim</namePart>
  <namePart type="family">Le Joncour</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Sarfaraz</namePart>
  <namePart type="family">Alam</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">123558353</identifier></name>
<name type="personal">
  <namePart type="given">Benjamin</namePart>
  <namePart type="family">Müller</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">17676839</identifier></name>
<name type="personal">
  <namePart type="given">Jayendrakishore Tanjore</namePart>
  <namePart type="family">Ramanathan</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Pirjo</namePart>
  <namePart type="family">Laakkonen</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Norbert</namePart>
  <namePart type="family">Sewald</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">20281</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0002-0309-2655</description></name>
<name type="personal">
  <namePart type="given">Kristian M.</namePart>
  <namePart type="family">Müller</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">17977</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Epidermal growth factor receptor (EGFR) is a validated tumor marker overexpressed in various cancers such as squamous cell carcinoma (SSC) of the head and neck and gliomas. We constructed protein-drug conjugates based on the anti-EGFR designed ankyrin repeat protein (DARPin) E01, and compared the bivalent DARPin dimer (DD1) and a DARPin-Fc (DFc) to the monomeric DARPin (DM) and the antibody derived scFv425-Fc (scFvFc) in cell culture and a mouse model. The modular conjugation system, which was successfully applied for the preparation of protein-drug and -dye conjugates, uses bio-orthogonal protein-aldehyde generation by the formylglycine-generating enzyme (FGE). The generated carbonyl moiety is addressed by a bifunctional linker with a pyrazolone for a tandem Knoevenagel reaction and an azide for strain-promoted azide-alkyne cycloaddition (SPAAC). The latter reaction with a PEGylated linker containing a dibenzocyclooctyne (DBCO) for SPAAC and monomethyl auristatin E (MMAE) as the toxin provided the stable conjugates DD1-MMAE (drug-antibody ratio, DAR = 2.0) and DFc-MMAE (DAR = 4.0) with sub-nanomolar cytotoxicity against the human squamous carcinoma derived A431 cells. In vivo imaging of Alexa Fluor 647-dye conjugates in A431-xenografted mice bearing subcutaneous tumors as the SCC model revealed unspecific binding of bivalent DARPins to the ubiquitously expressed EGFR. Tumor-targeting was verified 6 h post-injection solely for DD1 and scFvFc. The total of four administrations of 6.5 mg/kg DD1-MMAE or DFc-MMAE twice weekly did not cause any sequela in mice. MMAE conjugates showed no significant anti-tumor efficacy in vivo, but a trend towards increased necrotic areas (p = 0.2213) was observed for the DD1-MMAE (n = 5).</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="ijms-23-02468-v2.pdf">https://pub.uni-bielefeld.de/download/2961406/2961434/ijms-23-02468-v2.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>MDPI AG</publisher><dateIssued encoding="w3cdtf">2022</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>

<subject><topic>EGFR</topic><topic>DARPin</topic><topic>antibody-drug conjugates</topic><topic>MMAE conjugates</topic><topic>Knoevenagel ligation</topic><topic>formylglycine-generating enzyme</topic><topic>cytotoxicity</topic><topic>in vivo imaging</topic><topic>xenograft</topic><topic>SCC model</topic>
</subject>


<relatedItem type="host"><titleInfo><title>International Journal of Molecular Sciences</title></titleInfo>
  <identifier type="eIssn">1422-0067</identifier>
  <identifier type="MEDLINE">35269611</identifier>
  <identifier type="ISI">000771420200001</identifier><identifier type="urn">urn:nbn:de:0070-pub-29614067</identifier><identifier type="doi">10.3390/ijms23052468</identifier>
<part><detail type="volume"><number>23</number></detail><detail type="issue"><number>5</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<default>Karsten L, Janson N, Le Joncour V, Alam S, Müller B, Ramanathan JT, Laakkonen P, Sewald N, Müller KM (2022) &lt;br /&gt;&lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt; 23(5): 2468.</default>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Karsten, L., Janson, N., Le Joncour, V., Alam, S., Müller, B., Ramanathan, J. T., Laakkonen, P., et al. (2022). Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;, &lt;em&gt;23&lt;/em&gt;(5), 2468. &lt;a href="https://doi.org/10.3390/ijms23052468" target="_blank"&gt;https://doi.org/10.3390/ijms23052468&lt;/a&gt;&lt;/div&gt;</apa_indent>
<mla>Karsten, Lennard, Janson, Nils, Le Joncour, Vadim, Alam, Sarfaraz, Müller, Benjamin, Ramanathan, Jayendrakishore Tanjore, Laakkonen, Pirjo, Sewald, Norbert, and Müller, Kristian M. “Bivalent EGFR-Targeting DARPin-MMAE Conjugates”. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt; 23.5 (2022): 2468.</mla>
<frontiers>Karsten, L., Janson, N., Le Joncour, V., Alam, S., Müller, B., Ramanathan, J. T., Laakkonen, P., Sewald, N., and Müller, K. M. (2022). Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt; 23:2468.</frontiers>
<wels>Karsten, L.; Janson, N.; Le Joncour, V.; Alam, S.; Müller, B.; Ramanathan, J. T.; Laakkonen, P.; Sewald, N.; Müller, K. M. (2022): Bivalent EGFR-Targeting DARPin-MMAE Conjugates &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;,23:(5):2468</wels>
<apa>Karsten, L., Janson, N., Le Joncour, V., Alam, S., Müller, B., Ramanathan, J. T., Laakkonen, P., et al. (2022). Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;, &lt;em&gt;23&lt;/em&gt;(5), 2468. &lt;a href="https://doi.org/10.3390/ijms23052468" target="_blank"&gt;https://doi.org/10.3390/ijms23052468&lt;/a&gt;</apa>
<ieee> L. Karsten, et al., “Bivalent EGFR-Targeting DARPin-MMAE Conjugates”, &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;,  vol. 23, 2022, : 2468.</ieee>
<harvard1>Karsten, L., et al., 2022. Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;, 23(5): 2468.</harvard1>
<bio1>Karsten L, Janson N, Le Joncour V, Alam S, Müller B, Ramanathan JT, Laakkonen P, Sewald N, Müller KM (2022) &lt;br /&gt;Bivalent EGFR-Targeting DARPin-MMAE Conjugates.&lt;br /&gt;International Journal of Molecular Sciences 23(5): 2468.</bio1>
<angewandte-chemie>L.  Karsten, N.  Janson, V.  Le Joncour, S.  Alam, B.  Müller, J. T.  Ramanathan, P.  Laakkonen, N.  Sewald, and K. M.  Müller, “Bivalent EGFR-Targeting DARPin-MMAE Conjugates”, &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;, &lt;strong&gt;2022&lt;/strong&gt;, &lt;em&gt;23&lt;/em&gt;, : 2468.</angewandte-chemie>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Karsten, L., Janson, N., Le Joncour, V., Alam, S., Müller, B., Ramanathan, J.T., Laakkonen, P., Sewald, N. &amp;amp; Müller, K.M. (2022). Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;, &lt;em&gt;23&lt;/em&gt;(5): 2468. MDPI AG. doi:10.3390/ijms23052468.&lt;/div&gt;</dgps>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Karsten, Lennard, Janson, Nils, Le Joncour, Vadim, Alam, Sarfaraz, Müller, Benjamin, Ramanathan, Jayendrakishore Tanjore, Laakkonen, Pirjo, Sewald, Norbert, and Müller, Kristian M. 2022. “Bivalent EGFR-Targeting DARPin-MMAE Conjugates”. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt; 23 (5): 2468.&lt;/div&gt;</chicago>
<lncs> Karsten, L., Janson, N., Le Joncour, V., Alam, S., Müller, B., Ramanathan, J.T., Laakkonen, P., Sewald, N., Müller, K.M.: Bivalent EGFR-Targeting DARPin-MMAE Conjugates. International Journal of Molecular Sciences. 23, : 2468 (2022).</lncs>
<ama>Karsten L, Janson N, Le Joncour V, et al. Bivalent EGFR-Targeting DARPin-MMAE Conjugates. &lt;em&gt;International Journal of Molecular Sciences&lt;/em&gt;. 2022;23(5): 2468.</ama>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2961406</recordIdentifier><recordCreationDate encoding="w3cdtf">2022-02-24T06:15:54Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2022-04-04T13:03:09Z</recordChangeDate>
</recordInfo>
</mods>